Selective monoacylation of the antibiotic laidlomycin at C-26 has led to derivatives that display enhanced activity toward favorably altering rumen fermentation and preventing avian coccidiosis. Diacylated derivatives (C-7, C-26) were found to be inactive. The structures of these compounds were determined by 13C NMR spectroscopy.
The polyether ionophoric antibiotic laidlomycin (1)1,1' obtained from a strain of Streptomyces eurocidicus var. asterocidicus, bears a close structural resemblance to the monensins (e. g. monensin B, 2B).3 ' 4) The polyether ionophores have assumed considerable commercial importance as feed additives, enhancing feed efficiency in ruminants and acting as anticoccidial agents. Not surprisingly, laidlomycin also has activity that implies potential for both of these applications (vide infra). While investigating chemical modifications of laidlomycin we made the observation that acylation of the primary hydroxyl group (C-26) afforded compounds with a significantly enhanced profile in in vitro and in vivo activity re- 
13C NMR Studies
The 13C data for laidlomycin, 1, its sodium (1-Na) and potassium (1-K) salts and the sodium salts of monensin A (2A) and B (2B) are listed in Table 2 . The data for the potassium salts of the mono esters 3, 5, 6, and 8 -11 are contained in Table 3 while Table 4 contains the data for the potassium salts of the diesters 4, and 19-'22. The assignments of the methyl and methine carbons are based on selective decoupling and confirmed by application of BIRDSALL'S6) off-resonance technique which also served to identify C-26 and C-36. The quaternary carbons were assigned on the basis of chemical shift (C-1, C-9, C-25 and C-35) and by comparison with closely related structures (C-12 and C-16). C-16 was also distinguished from C-12 upon comparison of the spectra of monensins A and B. In the spectrum of 2B, C-16 is shifted 2.1 ppm upfield due to the removal of the methyl attached to C-30 in monensin A. The seven remaining methylenes were assigned by comparison with the spectra of mutalomycin7) (C-19 and C-23), dianemycin8) (C-8, C-10, and C-11), lenoremycin8) (C-23) and lonomycin7) (C-14 and C-15). spectroscopy10) is in complete agreement with these studies. Further multiple labelling and associated 13C{13C} decoupling experiments have completely established all the assignments for monensin A .")
The differences between the 13C NMR spectra of 2A and 2B are exactly those expected for the removal of the methyl group at C-30, i.e. an upfield shift of C-30 and C-16 and downfield shifts for C-15 and Similarly replacement of the 3-methoxy group in 2 with a propionate ester to give 1 is expected to give rise only to upfield shifts of C-2, C-3, and C-4.13) The expected shifts are observed for C-2 and C-3 but C-4 shifts downfield by 2.9
ppm. This downfield shift may be due to the anisotropy of the carbonyl group but is probably due to 1 adopting a conformation different than that of 2B. The only other significantly different shift between 2B and 1 is observed for C-32 and is probably also due to a slightly altered conformation.
The large differences observed between the spectra of 1, 1-Na, and 1-K indicate substantial conformational changes which are dependent on the nature of the cation. Acylation of the 7-hydroxyl group does lead to the expected shifts13) of C-6, C-7, and C-8 as has been reported for monensin A.9 Since the 7-OH group is one of the metal ligands in monensin A and therefor presumably in 1, acylation of this group might be expected to influence the strength of coordination, the conformation of the molecule and its biological activity. Shift differences of 0.1 ppm or greater are observed for almost every carbon in the diesters as compared to the monoesters. These changes in chemical shift cannot be attributed only to acylation of the OH group but point to large conformational changes throughout the molecule.
Biological Testing
Two in vitro assays were used to determine the potential efficacy of laidlomycin esters as feed additives for ruminants.15) For both assays, fluid digest obtained from a rumen-fistulated bovine was mixed with an appropriate buffer and after administration of test compound, the production of volatile fatty acids (VFA) or lactic acid was measured.
It has been established that the feed efficiency enhancing activity of monensin A is related to the enhancement of intraruminal propionic acid production.16) Thus an in vitro fermentation model which simulated a normal rumen environment was used in which propionic acid production was measured at various concentrations of test compound.
The results of this screen, represented as percentage increase in propionic acid relative to control, are presented in Table 5 .
A second characteristic desirable for a feed additive for ruminants is related to the prevention of lactic acidosis.17) This condition, which sometimes occurs when animals are introduced to a high concentrate diet in the feedlot, appears to be due to an initial rapid proliferation of the lactate producing rumen bacterium Streptococcus bovis.18) Clinical signs of lactic acidosis may range from loss of appetite to death. A propionate enhancing antibiotic which would also inhibit the development of lactic aci-dosis could afford a demonstrable advantage over the feed additives currently available. Thus a second fermentation model designed to simulate the intraruminal environment under conditions conducive to lactic acidosis (low buffering capacity, high substrate availability) was used to test compounds for their potential in preventing lactic acid production. Results are presented in Table 5 as percentage of lactic acid produced relative to control.
Anticoccidial efficacy was determined in vivo with Eimeria tenella infected chicks. Compounds were evaluated based upon (1) prevention of mortality due to coccidiosis, (2) maintenance of body weight gain, and (3) intestinal tract lesions which were scored on a scale of 0 to 4 based upon their number and severity. Results are presented in Table 6 .
Results
As shown in Table 5 monoacylation of laidlomycin generally led to compounds with enhanced ac- Acetate (3) Propionate (5) Butyrate (6) Isobutyrate (7) Cyclopropanecarboxyl (8) Pentanoate (9) Cyclobutanecarboxyl (10) Hexanoate (11) Cyclopentanecarboxyl (12) Heptanoate (13) Cyclohexanecarboxyl (14) Octanoate (15) Decanoate (16) Dodecanoate (17) Stearate (18) Diacetate (4) Dipropionate ( tivity toward increasing propionic acid production and decreasing lactic acid production. Diacylation led to compounds which were inactive as propionate enhancers. Among the monoacyl derivatives, the four carbon esters 6 and 7 were the best propionate enhancers although probably not statistically significantly different from several of the other homologs. The same trend was present in the lactic acid inhibition rate which indicated that 6, 7, and 8 were the most active compounds. From this series, the butyrate (6) was selected for evaluation as a ruminant growth promoter. This compound at 1.25 trg/ ml, a concentration that may roughly approximate that used for monensin in vivo, effectively increased propionic acid 40 % over control levels while inhibiting lactic acid to 15 % of control. To achieve comparable results, concentration of 5 jig/ml or greater of laidlomycin were required. The in vitro activity of 6, especially in terms of lactic acid inhibition, was also superior to that of monensin A (Table 5 ).
Of the compounds tested in the anticoccidial screen, the propionate ester 5 at 125 ppm was superior to laidlomycin at the same dose and comparable to monensin at 100 ppm by all three of the evaluative criteria ( Table 6 ).
The reason for the enhanced activity of the monoacylated laidlomycins is only a matter of conjecture at t.lis time. It is attractive to speculate that the acylation of the C-26 hydroxyl may enhance the ionophoric properties of the molecule by covering the C-7 hydroxyl thus contributing to the hydrophobic exterior of the ionophore as it wraps around an ion. Diacylation may seriously perturb the chelative properties and/or conformation of the molecule thereby leading to inactive derivatives. However, the increased activity of the monoacyl compounds could also be due to metabolic or transport phenomena and further study would be required to clarify this point.
In conclusion, we have demonstrated that acylation of laidlomycin at C-26 leads to compounds with a superior profile of antibiotic activity relative to the parent compound in two in vitro rumen fer- Laidlomycin (1) Monensin (2) Laidlomycin propionate (5) Laidlomycin butyrate (6) Laidlomycin hexanoate (11) Laidlomycin octanoate (15) Laidlomycin decanoate (16) Infected controls
Non-infected controls 
Experimental
1H NMR spectra were measured on a Bruker WM-300 in CDCl3 solution containing tetramethylsilane as an internal standard. The pulse width was 4 microseconds (80° flip angle), the spectral width 3KHz, using a 32K data table giving a digital resolution of 0.2 Hz. Concentrations were 50-200 mg/ ml. Four or eight transients were collected using quadrature detection. The proton chemical shifts were observed to be concentration dependent but no effort was made to determine the nature of this dependence. 13C NMR spectra were determined using Bruker WM-300 (75.475 MHz) or WH-90 (22.62 MHz) spectrometers. The samples were dissolved in CDCl3 containing tetramethylsilane and placed in 5 or 10 mm NMR tubes. The spectrometer parameters were as follows: WM-300/WH-90 spectral width 18/6 KHz, pulse width 6.5/5 microseconds, data table 32/16 K, digital resolution 1.1/0.7 Hz, repetition rate 0.44/0.7 sec., a 1.0 Hz line broadening function was applied to the 13C FID before Fourier transformation.
For the selective decoupling experiments, the decoupler frequencies were determined on the same solution by using either a dual frequency 1H-13C-5 mm probe or by using the decoupler coils of the 10 mm probe to observe the 'H spectrum. 1,000 to 80,000 transients were collected for each spectrum. Monensin A was purchased from Calbiochem, LaJolla, CA. Monensin B were gifts of Prof. DAVID CANE, Brown University and Drs. DOUG DORMAN and ROBERT HAMILL of Eli Lilly and Co. Melting points were uncorrected; infrared spectra were recorded with a Perkin-Elmer 237b spectrometer. Silica gel for column chromatography was that of Merck (Darmstadt), 70-230 mesh. Microanalyses were performed by Syntex Analytical Research.
Laidlomycin Diacetate (4) To a solution of 1.0 g sodium laidlomycin (1) in 10 ml of pyridine, cooled in an ice bath, was added 0.7 ml of acetyl chloride.
The solution was stored for 24 hours at 5°C and then diluted with dichloromethane and washed twice with dilute aqueous hydrochloric acid.
Evaporation of the solvent and chromatography of the residue on silica gel (elution with ethyl acetate) gave 0. A solution of 0.15 g of laidlomycin (1) in 5 ml of pyridine was cooled in an ice bath and 0.3 ml of butyryl chloride was added.
The solution was allowed to warm to room temperature over 3 hours and was partitioned between dichloromethane and dilute aqueous hydrochloric acid. The dichloromethane was evaporated to an oil which was filtered through silica gel with ethyl acetate elution to afford 0. Compounds for testing were transferred into 18 x 150 mm incubation tubes and appropriate rumen fluid-buffer was pipetted into each incubation tube to bring the volume to 10 ml. All tubes were fitted with gas-release stoppers and were incubated in a shaking water bath at 39°C. Fermentation was terminated at 5.5 hours for the lactic acid fermentations and at 9 hours for the volatile fatty acid fermentations by addition of 2 ml of 25 % metaphosphoric acid to the incubation tubes. Aliquots were centrifuged at 30,000 x g for 10 minutes, and the resulting supernate was analyzed for 1(+)-lactic acid or volatile fatty acids. 1(+)-Lactic acid was analyzed via a specific enzymatic assay. Volatile fatty acids were analyzed via gas chromatography. The instrument used was a Perkin-Elmer 900B equipped with a hydrogen flame ionization detector. The acids were separated on a stainless-steel column (0.32X 182.9 cm) packed with 10% SP-1200/1% H3PO4 on Chromosorb-WAW, 80-100 mesh. The following additional chromatographic conditions were employed: column temperature, 145°C; injector temperature, 190°C: detector temperature, 190°C; carrier gas flow, 45 ml/minute; injection volume, 1 ul. Duplicate incubations for the lactic acid fermentation model and triplicate incubations for the volatile fatty acid fermentation model were conducted for each level of compound tested.
